Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.680 | 3.680 | 0.000 |
Shares | 93.280 | 93.280 | 0.000 |
Bonds | 2.840 | 2.840 | 0.000 |
Other | 0.210 | 0.210 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 36.284 | 24.124 |
Price to Book | 4.201 | 3.013 |
Price to Sales | 4.539 | 3.867 |
Price to Cash Flow | 15.857 | 15.880 |
Dividend Yield | 0.239 | 1.889 |
5 Years Earnings Growth | 7.046 | 13.292 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 96.950 | 95.436 |
Consumer Defensive | 3.040 | 3.141 |
Technology | 0.010 | 0.421 |
Number of long holdings: 65
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 9.68 | 44.04 | -2.16% | |
Keymed Biosciences Inc | - | 8.95 | - | - | |
Akeso | KYG0146B1032 | 8.63 | 57.40 | -3.29% | |
Hutchison China | KYG4672N1198 | 8.43 | 247.06 | -3.11% | |
Innovent Biologics | KYG4818G1010 | 8.17 | 35.15 | -0.42% | |
RemeGen | CNE100005B03 | 5.93 | 27.61 | +0.47% | |
Beigene | CNE100005XT6 | 5.86 | 156.21 | -0.38% | |
Sichuan Kelun Biotech | CNE1000062J1 | 5.63 | 167.00 | -1.36% | |
Hansoh Pharmaceutical Group | KYG549581067 | 4.22 | 16.32 | -1.57% | |
TREASURY COUPON BOND 2023 16 | - | 2.88 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BOC Income Mixed Securities Inves A | 2.36B | -1.97 | -8.56 | 10.50 | ||
BOC Income Mixed Securities Inves H | 2.36B | -1.94 | -8.56 | - | ||
Industrial Dynamic Asset Al Mix | 1.76B | -1.81 | -12.60 | 10.67 | ||
BOC Intelligent manufacturing Eq | 1.73B | 7.06 | -10.39 | - | ||
BOC Thematic Strategy Stock | 1.72B | -1.65 | -7.87 | 8.38 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review